Omnicell, Inc. Omnicell, Inc.

Omnicell, Inc.

OMCL

Rank in Stocks #6516
Omnicell, Inc., together with its subsidiaries, provides healthcare technology... Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Share Price
$37.35
Last synced: 2026-11-09
Market Cap
$1.70B
Change (1 day)
0.03%
Change (1 year)
1.33%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Omnicell, Inc. (OMCL)
Operating Margin as of November 2026 TTM: 5.28%
According to Omnicell, Inc.'s latest financial reports, its current operating margin (TTM) is 5.28%. At the end of 2025 the company had an operating margin of 0.98%.
Operating Margin history for Omnicell, Inc. from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 5.28% 438.78%
2025 0.98% 3,166.67%
2024 0.03% -101.78%
2023 -1.69% 838.89%
2022 -0.18% -102.28%
2021 7.91% 98.74%
2020 3.98% -54.41%
2019 8.73% 54.79%
2018 5.64% 605.00%
2017 0.80% -14.89%
2016 0.94% -90.64%
2015 10.04% -10.76%
2014 11.25% 21.36%
2013 9.27% 7.54%
2012 8.62% 30.41%
2011 6.61% 54.44%
2010 4.28% 1,280.65%
2009 0.31% -95.49%
2008 6.88% -19.53%
2007 8.55% 42.98%
2006 5.98% -368.16%
2005 -2.23% -126.20%
2004 8.51% 24.42%
2003 6.84% -201.63%
2002 -6.73% 1,273.47%
2001 -0.49% -98.31%
2000 -29.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
22.24% -95.79%
US
-3.59% -100.68%
US
0.53% -99.90%
US
0.00% -100.00%
IL
9.00% -98.30%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Omnicell, Inc.'s operating margin

What is Omnicell, Inc.'s operating margin?

Omnicell, Inc.'s operating margin is 5.28%, as of Nov 2026.

What was Omnicell, Inc.'s operating margin in 2025?

In 2025, Omnicell, Inc.'s operating margin was 0.98%, compared with 0.03% in 2024.

How has Omnicell, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Omnicell, Inc.'s operating margin was highest in 2021 (7.91%) and lowest in 2023 (-1.69%).

How does Omnicell, Inc.'s operating margin compare with similar companies?

Omnicell, Inc.'s operating margin (5.28%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Sirona Dental Systems, Inc., with 22.24%.